Patents by Inventor Ian Johnson

Ian Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240131072
    Abstract: Activity-inducible fusion proteins whose activity is post-translationally regulated utilizing a hsp90 binding domain and a drug molecule are described. In the absence of the drug molecule, the activity-inducible fusion proteins are inactivated but can be activated by a relevant physiological parameter in the presence of the drug molecule. Examples of the activity-inducible fusion proteins include chimeric antigen receptors (CAR) wherein the relevant physiological parameter is antigen binding.
    Type: Application
    Filed: February 11, 2022
    Publication date: April 25, 2024
    Applicant: Seattle Children's Hospital d/b/a Seattle Children's Research Institute
    Inventors: Ryan Koning, Adam Johnson, Chris Saxby, Michael C. Jensen, Ian Blumenthal, Aquene Reid
  • Patent number: 11964696
    Abstract: Embodiments of the present invention provide a structural frame for a body of a motor vehicle, the structural frame defining, at least in part, an occupant compartment of the vehicle, the structural frame comprising a pair of spaced pillars joined together at an upper region of each pillar to a roof crossmember and further joined together at respective points below the roof crossmember to a structural cross-brace, the structural cross-brace is further arranged to support a pair of spaced apart vehicle suspension connectors and, wherein the structural cross-brace projects from the pillars beyond the suspension connectors so that the space in the occupant compartment between the pillars is substantially unobstructed by the structural cross-brace and, at least a portion of the structural cross-brace is accommodated within the occupant compartment.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: April 23, 2024
    Assignee: JAGUAR LAND ROVER LIMITED
    Inventors: Raidan Alhuraibi, David Wier, Jonathan Mabey, Mat Burgess, Ian Johnson, Martin Wheeler
  • Publication number: 20240082472
    Abstract: A blood treatment system with pressure sensors may be configured to control blood flow to and from the patient and use readings of the pressure sensors to determine a change in a pressure drop across a flow restriction in the blood circuit to estimate a condition of the machine or the patient, or outputting data responsive to the estimation. Further embodiments employ measurement of pressure drop to detect abnormal viscosity or viscosity variations in order to detect possible infection.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 14, 2024
    Applicant: NxStage Medical, Inc.
    Inventors: Mark T. WYETH, Robert Paul MCCARTY, Gregory YANTZ, James Ian JOHNSON, Joseph E. TURK, JR., James M. BRUGGER, Jeffrey H. BURBANK
  • Publication number: 20240026984
    Abstract: Fluid channel sealing devices, frangible seals, fluid circuits, associated controllers and methods of using the same are provided for controlling fluid distribution using a reconfigurable blocking element having first and second portions to establish a first configuration free of any open channels such that fluid is prevented from flowing through the channel and a second configuration where the first and second portions are separated to establish an open channel and allow fluid to pass.
    Type: Application
    Filed: October 5, 2023
    Publication date: January 25, 2024
    Applicant: NxStage Medical, Inc.
    Inventors: Gregory YANTZ, Mark T. WYETH, James Ian JOHNSON, William J. SCHNELL
  • Publication number: 20240018458
    Abstract: This disclosure describes methods and apparatuses for creating or using a fibrous cell substrate that is formed in a mold using temperature and wettability gradients and that upon which cells can be grown. The disclosed method can include utilizing a temperature gradient and a wettability gradient within a mold to form a porous cell substrate. In particular, the temperature and wettability gradients control nucleation and growth of crystals within the cell substrate solution to form parallel layers of cell substrate. The crystals can be sublimated by freeze drying and the porous cell substrate is seeded. More specifically, the disclosed method includes using pressure and an increased cell mixture viscosity to seed cells deep within the cell substrate. This disclosure also describes an apparatus for forming the structured porous cell substrate.
    Type: Application
    Filed: July 12, 2023
    Publication date: January 18, 2024
    Inventors: Leila Mohammadiamirabad, John Pattison, Ian Johnson, Vaishnavee Patil
  • Patent number: 11865243
    Abstract: A blood treatment system with pressure sensors may be configured to control blood flow to and from the patient and use readings of the pressure sensors to determine a change in a pressure drop across a flow restriction in the blood circuit to estimate a condition of the machine or the patient, or outputting data responsive to the estimation. Further embodiments employ measurement of pressure drop to detect abnormal viscosity or viscosity variations in order to detect possible infection.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: January 9, 2024
    Assignee: NxStage Medical, Inc.
    Inventors: Mark T. Wyeth, Robert Paul McCarty, Gregory Yantz, James Ian Johnson, Joseph E. Turk, Jr., James M. Brugger, Jeffrey H. Burbank
  • Patent number: 11815189
    Abstract: Fluid channel sealing devices, frangible seals, fluid circuits, associated controllers and methods of using the same are provided for controlling fluid distribution using a reconfigurable blocking element having first and second portions to establish a first configuration free of any open channels such that fluid is prevented from flowing through the channel and a second configuration where the first and second portions are separated to establish an open channel and allow fluid to pass.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: November 14, 2023
    Assignee: NxStage Medical, Inc.
    Inventors: Gregory Yantz, Mark T. Wyeth, James Ian Johnson, William J. Schnell
  • Patent number: 11697965
    Abstract: A ladder safety mechanism comprises at least one clamp, preferably a pair of spaced apart clamps, attachable part way along a ladder, to secure the ladder to part of a structure. In some embodiments, the mechanism includes at least one manually operated actuator, such as a rope or cable, coupled to the at least one clamp to enable a user located at the bottom of the ladder to open the at least one clamp to receive the part of a structure. In some embodiments, the at least one clamp is automatically secured to the part of the structure by placing the clamp onto the structure. The at least one manually operated actuator also enables a user located at the bottom of the ladder to open the at least one clamp to release the part of the structure. The at least one clamp is oriented substantially perpendicularly to a part of the structure to which the ladder is to be attached.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: July 11, 2023
    Assignee: OD TECH PTY LTD
    Inventors: Peter O'Donnell, Ian Johnson, George Rezk
  • Publication number: 20220295316
    Abstract: There is provided a method and apparatus for managing communication characteristics in a wireless network. The method includes obtaining, by the network device, information indicative of operational characteristics of one or more of a configuration of a deployed network, signal strength, network congestion and the network device and determining a degradation associated with each of the one or more of the configuration of the deployed network, the signal strength, the network congestion and the network device, based at least in part on the obtained information. In some embodiments, the method further includes determining an extent of speed degradation based on each of the determined degradations.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 15, 2022
    Inventors: Gustav Gerald Vos, Derrell D'Souza, Andrew Ian Johnson
  • Publication number: 20220287609
    Abstract: An electrode configured to adhere to a patient's skin to conduct electrical potentials therefrom includes a substrate, a skin adhesive configured to adhere the electrode to a patient's skin, and a conductor plate mounted on the substrate. A conductive gel is configured to contact the patient's skin and to conduct electrical potentials from the patient's skin to the conductor plate when the electrode is adhered to the patient's skin. A removable separator is positioned between the conductive gel and the conductor plate, wherein the removable separator is configured to be removed prior to operating the electrode to conduct electrical potentials.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 15, 2022
    Applicant: GE Precision Healthcare LLC
    Inventors: Robert Brendan Smith, Christopher Ian Johnson
  • Patent number: 11397083
    Abstract: Gyroscope data can be used to generate upsampled signal. Multiple mobile devices are spaced apart from each other in a spatial arrangement. Each mobile device includes a gyroscope sensor to detect mechanical vibrations caused by signals originating within a vicinity of a mobile device that includes the gyroscope sensor. Each mobile device includes one or more respective processors to receive representations of the mechanical vibrations sensed by the gyroscope sensor at a sampling frequency, and transmit the representations received at the sampling frequency as a respective vibration signal associated with sampling times. The signal processor is coupled to the multiple mobile devices. The signal processor generates a processed upsampled signal by interleaving the vibration signal received from each mobile device and processing the interleaved signal using one or more machine learning filters, and transmitting the processed upsampled signal.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: July 26, 2022
    Assignee: IRONWOOD CYBER INC.
    Inventors: Eric C. Larson, Mitchell Thornton, Ian Johnson, Travis Siems, Erik Gabrielsen
  • Patent number: 11357993
    Abstract: A medical lead includes a lead body, an electrical connector, an electrical conductor, and a sleeve. The lead body includes a distal end and a proximal end defining a longitudinal axis of the lead body. The electrical connector is positioned near the proximal end of the lead body. The electrical conductor extends about the longitudinal axis of the lead body. The sleeve is coupled to an insulative material of the lead body and positioned around the electrical conductor. The electrical conductor is electrically coupled to the electrical connector. The sleeve is not fixed to the electrical conductor. In response to bending of the medical lead, the conductor may move within the sleeve to relieve strain created by the bending.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: June 14, 2022
    Assignee: Medtronic, Inc.
    Inventors: Jeffrey Zweber, Joseph Bradley, Vincent Whelan, Ian Johnson, Sean P. Skubitz
  • Publication number: 20220074511
    Abstract: Fluid channel sealing devices, frangible seals, fluid circuits, associated controllers and methods of using the same are provided for controlling fluid distribution using a reconfigurable blocking element having first and second portions to establish a first configuration free of any open channels such that fluid is prevented from flowing through the channel and a second configuration where the first and second portions are separated to establish an open channel and allow fluid to pass.
    Type: Application
    Filed: September 25, 2019
    Publication date: March 10, 2022
    Applicant: NxStage Medical, Inc.
    Inventors: Gregory YANTZ, Mark T. WYETH, James Ian JOHNSON, William J. SCHNELL
  • Patent number: 11266828
    Abstract: A medical lead includes a lead body, a connector, an electrical conductor, and a sleeve. The lead body includes a distal end and a proximal end defining a longitudinal axis of the lead body. The connector is positioned near the proximal end of the lead body. The electrical conductor extends about the longitudinal axis of the lead body. The sleeve is coupled to an insulative material of the lead body and positioned around the electrical conductor. The electrical conductor is electrically coupled to the connector. The sleeve includes a fixed portion that is fixed to the electrical conductor and an unfixed portion that is not fixed to the electrical conductor. In response to bending of the medical lead, the conductor may move within the unfixed portion to relieve strain created by the bending.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: March 8, 2022
    Assignee: Medtronic, Inc.
    Inventors: Jeffrey Zweber, Joseph Bradley, Vincent Whelan, Ian Johnson
  • Publication number: 20220017148
    Abstract: Embodiments of the present invention provide a structural frame for a body of a motor vehicle, the structural frame defining, at least in part, an occupant compartment of the vehicle, the structural frame comprising a pair of spaced pillars joined together at an upper region of each pillar to a roof crossmember and further joined together at respective points below the roof crossmember to a structural cross-brace, the structural cross-brace is further arranged to support a pair of spaced apart vehicle suspension connectors and, wherein the structural cross-brace projects from the pillars beyond the suspension connectors so that the space in the occupant compartment between the pillars is substantially unobstructed by the structural cross-brace and, at least a portion of the structural cross-brace is accommodated within the occupant compartment.
    Type: Application
    Filed: November 29, 2019
    Publication date: January 20, 2022
    Inventors: Raidan ALHURAIBI, David WIER, Jonathan MABEY, Mat BURGESS, Ian JOHNSON, Martin WHEELER
  • Publication number: 20210308349
    Abstract: Peritoneal dialysis admixing and/or treatment devices, methods, and systems are disclosed. The systems, methods, and devices provide high-level guarantees of sterility and employs relatively inexpensive disposable components to provide pumping. Disclosed systems, methods, and devices and features thereof are adapted for point of use generation of medicament. In particular admixing systems that employ independently-replaceable long term concentrate are disclosed. Features are directed to assurance of sterility and accurate admixing of water and concentrate to generate ready-to-use medicaments and other benefits.
    Type: Application
    Filed: June 24, 2018
    Publication date: October 7, 2021
    Applicant: NxStage Medical, Inc.
    Inventors: Mark T. WYETH, Gregory YANTZ, James Ian JOHNSON, James M. BRUGGER, Dennis M. TREU, Dritan KURSHUMI, Jeffrey H. BURBANK, William J. SCHNELL, Robert Paul MCCARTY
  • Patent number: 11058826
    Abstract: A replaceable needle assembly is provided for a retractable, prefilled syringe comprising a barrel having a mounting member and a plunger, whereby the retractable needle can be replaced by a user without affecting the retraction mechanism. The replaceable needle assembly comprises a needle fitted to a retractable needle mount and a needle retainer. The needle mount is removably, screw-threadedly mountable to the mounting member of the barrel. The needle retainer comprises a plurality of fingers that releasably engage the retractable needle to thereby prevent inadvertent retraction of the retractable needle before engagement by the plunger. The plunger comprises a plunger seal comprising an outer member and an inner member that engages the needle for spring-driven retraction. At the end of retraction, a lock is formed between the plunger and barrel to prevent re-use of the syringe.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: July 13, 2021
    Assignee: UNL Holdings LLC
    Inventors: Craig Stephen Thorley, Joseph Hermes Kaal, Christopher Charles Rafferty, Ian Johnson, Eric Siu, Andrew Reade
  • Patent number: 11021376
    Abstract: A water network monitor, monitoring system and method? A water network monitor, monitoring system and method comprising: at least one sensor operable to sense one or more parameters of a water network; and an analyser to analyse data points over time from the water network by the at least one sensor, the analyser having an input comprising the data points recorded over time from the water network and an output comprising an event probability P(event) that an event has occurred which affects the water network from which the data points were recorded, the analyser comprising: an outlier detector to determine a measure of abnormality (D) from an outlier detection algorithm for each of the data points; and an outlier decay discriminator (ODD) to calculate an outlier probability (Po) for each of the data points based on each data points measure of abnormality (D), wherein the outlier probability is decayed over time, the output of the ODD comprising an event probability P(event), wherein P(event) is based on the d
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: June 1, 2021
    Assignee: INTELLITECT WATER LTD
    Inventors: Benjamin Ian Johnson, Alexander James Brown, Mark Duckworth
  • Publication number: 20200331772
    Abstract: A water network monitor, monitoring system and method comprising: at least one sensor operable to sense one or more parameters of a water network; and an analyser to analyse data points recorded over time from the water network by the at least one sensor, the analyser having an input comprising the data points recorded over time from the water network and an output comprising an event probability P(event) that an event has occurred which affects the water network from which the data points were recorded, the analyser comprising: an outlier detector to determine a measure of abnormality (D) from an outlier detection algorithm for each of the data points; and an outlier decay discriminator (ODD) to calculate an outlier probability (Po) for each of the data points based on each data points measure of abnormality (D), wherein the outlier probability is decayed over time, the output of the ODD comprising an event probability P(event), wherein P(event) is based on the decayed outlier probability.
    Type: Application
    Filed: August 10, 2018
    Publication date: October 22, 2020
    Inventors: Benjamin Ian JOHNSON, Alexander James BROWN, Mark DUCKWORTH
  • Publication number: 20200289831
    Abstract: A medical lead includes a lead body, an electrical connector, an electrical conductor, and a sleeve. The lead body includes a distal end and a proximal end defining a longitudinal axis of the lead body. The electrical connector is positioned near the proximal end of the lead body. The electrical conductor extends about the longitudinal axis of the lead body. The sleeve is coupled to an insulative material of the lead body and positioned around the electrical conductor. The electrical conductor is electrically coupled to the electrical connector. The sleeve is not fixed to the electrical conductor. In response to bending of the medical lead, the conductor may move within the sleeve to relieve strain created by the bending.
    Type: Application
    Filed: May 29, 2020
    Publication date: September 17, 2020
    Inventors: Jeffrey Zweber, Joseph Bradley, Vincent Whelan, Ian Johnson, Sean P. Skubitz